VICENTE VALERO to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications VICENTE VALERO has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.109
-
Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature. Ann Oncol. 2005 Aug; 16(8):1289-96.
Score: 0.053
-
Combination docetaxel/cyclophosphamide in patients with advanced solid tumors. Oncology (Williston Park). 1997 Aug; 11(8 Suppl 8):34-6.
Score: 0.031
-
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer. Semin Oncol. 1995 Apr; 22(2 Suppl 4):17-21.
Score: 0.026